Cargando…
Patients’ experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study
BACKGROUND: There is increasing evidence suggesting that open-label placebo (OLP) is an effective treatment for several medical conditions defined by self-report. However, little is known about patients’ experiences with OLP, and no studies have directly compared patients’ experiences in double-blin...
Autores principales: | Haas, Julia W., Ongaro, Giulio, Jacobson, Eric, Conboy, Lisa A., Nee, Judy, Iturrino, Johanna, Rangan, Vikram, Lembo, Anthony, Kaptchuk, Ted J., Ballou, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815135/ https://www.ncbi.nlm.nih.gov/pubmed/35120572 http://dx.doi.org/10.1186/s40359-022-00731-w |
Ejemplares similares
-
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
por: Ballou, Sarah, et al.
Publicado: (2017) -
Symptom perception, placebo effects, and the Bayesian brain
por: Ongaro, Giulio, et al.
Publicado: (2019) -
Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome
por: Wang, Rui-Sheng, et al.
Publicado: (2022) -
Emergency department burden of hyperemesis gravidarum in the United States from 2006 to 2014
por: Geeganage, Grace, et al.
Publicado: (2023) -
Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia
por: Singh, Prashant, et al.
Publicado: (2019)